Entrepreneurship & Innovation · Innovation Management

BioForge: Biotech Portfolio Management

Simulation to teach biotech R&D portfolio strategy, clinical trial management, and commercialization decisions through the role of Chief Scientific Officer at a LATAM biotech company

5 rounds Executive English, Español

Preview

Who it is for

An advanced simulation for participants used to working with the main frameworks and trade-offs of the subject, designed for executive education and experienced professionals.

How a session runs

  1. The instructor creates a session from the Eureka dashboard and invites the participants.
  2. Participants play 5 rounds. In each one they submit their decisions and the simulation calculates the results.
  3. The simulation can be run in English, Español.
  4. The instructor follows each participant's progress and results from the dashboard, and uses the class results for the debrief.

Decisions participants make

The decisions participants make during the simulation:

  • Portfolio Strategy
  • R&D Allocation to Novel Programs (%)
  • Partnership Approach
  • GF-1001 (IL-6 Inhibitor) Decision
  • GF-1004 (Gene Therapy) Decision
  • GF-1003 (GLP-1) Strategy
  • Roche In-License Deal
  • Capital Strategy
  • Novartis Renegotiation
  • Disclosure Strategy

Subjects covered

Designed for courses in Innovation Management.

  • Healthcare Marketing
  • Technology Commercialization & Tech Transfer

Ready to use BioForge: Biotech Portfolio Management with your students?

Contact us and we'll set you up with a free trial session.

Contact us